TITLE

Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress

AUTHOR(S)
Balkan, J.; Doğru-Abbasoğlu, S.; Kanbāgli Ö.; Çevikbaş, U.; Aykaç-Toker, G.; Uysal, M.
PUB. DATE
May 2001
SOURCE
Human & Experimental Toxicology;May2001, Vol. 20 Issue 5, p251
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Thioacetamide (TAA) administration (0.3 g/l of tap water for a period of 3 months) to rats resulted in hepatic cirrhosis as assessed by biochemical and histopathological findings. This treatment caused an increase in the levels of malondialdehyde (MDA) and diene conjugates (DCs) and a decrease in the levels of glutathione (GSH), vitamin E, vitamin C and the activities of glutathione peroxidase (GSH-Px) in the liver of rats. Superoxide dismutase (SOD) activities were unchanged. Taurine (2% w/w, added to the chow diet) was administered together with TAA (0.3 g/l of drinking water) for 3 months. Taurine was found to decrease TAA-induced hepatic lipid peroxidation and to increase TAA-depleted vitamin E levels and GSH-Px activities. Histopathological findings also suggested that taurine has an inhibitive effect on TAA-induced hepatic cirrhosis. These results indicate that taurine treatment has a protective effect against TAA-induced liver cirrhosis by decreasing oxidative stress. Human & Experimental Toxicology (2001) 20, 251–254.
ACCESSION #
4886214

 

Related Articles

  • Effect of Antioxidant Treatment on Fibrogenesis in Rats with Carbon Tetrachloride-Induced Cirrhosis. Bona, Silvia; Filippin, Lidiane Isabel; Di Naso, FábioCangeri; de David, Cintia; Valiatti, Bruna; Schaun, Maximiliano Isoppo; Xavier, Ricardo Machado; Marroni, Norma Possa // ISRN Gastroenterology;2012, p1 

    Aim. This study aimed to assess the antioxidant activity of quercetin (Q) in an experimental model of cirrhosis induced by CCl4 inhalation. Materials and Methods. We used 25 male Wistar rats (250 g) that were divided into 3 groups: control (CO), CCl4, and CCl4 + Q. The rats were subjected to...

  • Protective effect of aqueous extract of Leonotis nepaetifolia (L.)R.Br.on CCL4 induced hepatic damage. Radhika, J.; Pradeep, V.; Brindha, P. // Journal of Pharmacy Research;Mar2011, Vol. 4 Issue 3, p630 

    Liver is one of the most important organs in the biotransformation of food, drugs, and endogenous and exogenous substances. Herbal plants have been recently popularized in modern medicine, since many therapeutically important compounds are derived from them. From the literature review it is...

  • Prescribing Medications in Patients with Decompensated Liver Cirrhosis. Amarapurkar, Deepak N. // International Journal of Hepatology;2011, p1 

    Patients with decompensated liver cirrhosis have various serious complications which require multiple drugs for therapeutic or prophylactic use. Majority of the drugs are primarily metabolized and excreted by hepatobiliary system; hence, liver cell necrosis contributes to impaired drug handling...

  • Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver. Iguchi, Hiroyoshi; Oda, Masaya; Yamazaki, Hitoshi; Yokomori, Hiroaki // Medical Molecular Morphology;Sep2013, Vol. 46 Issue 3, p123 

    The pathophysiology of arterial capillary proliferation accompanying fibrosis in human cirrhosis remains unclear. However, evidence regarding the molecules participating in the pathophysiological process has been accumulating. Water channel proteins known as aquaporins (AQP)s, notably AQP-1,...

  • Thalidomide Accelerates the Degradation of Extracellular Matrix in Rat Hepatic Cirrhosis via Down-Regulation of Transforming Growth Factor-β1. Peng Lv; Qingshun Meng; Jie Liu; Chuanfang Wang // Yonsei Medical Journal;Nov2015, Vol. 56 Issue 6, p1572 

    Purpose: The degradation of the extracellular matrix has been shown to play an important role in the treatment of hepatic cirrhosis. In this study, the effect of thalidomide on the degradation of extracellular matrix was evaluated in a rat model of hepatic cirrhosis. Materials and Methods:...

  • Emodinamica epatica: dalla sfera della ricerca alla pratica clinica? Puoti, Claudio; Bellis, Lia // Italian Journal of Medicine;Sep2010, Vol. 4 Issue 3, p201 

    Summary: Portal hypertension is a progressive complication of cirrhosis. Therefore, the management of a patient with cirrhosis and gastrointestinal bleeding depends largely on the stage of the portal hypertension. The patient may be in the pre-variceal stage or present with acute variceal...

  • Refractory gastric antral vascular ectasia: a new endoscopic approach. ZULLI, C.; DEL PRETE, A.; ROMANO, M.; ESPOSITO, F.; AMATO, M. R.; ESPOSITO, P. // European Review for Medical & Pharmacological Sciences;Nov2015, Vol. 19 Issue 21, p4119 

    Gastric antral vascular ectasia (GAVE) is an uncommon disorder observed in patients with liver cirrhosis, causing upper gastro-intestinal haemorrhage. GAVE is diagnosed through esophagogastroduodenoscopy and is characterized by the presence of visible columns of red tortuous enlarged vessels...

  • Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. Franca, Alex Vianey Callado; Giordano, Helena maria; Sev á-Pereira, Tiago; Soares, Elza Cotrim // Journal of Gastroenterology;2002, Vol. 37 Issue 2, p119 

    Background. The aim of this study was to determine whether a short course of ceftriaxone was sufficient to cure spontaneous bacterial peritonitis (SBP) in cirrhotic patients. Methods. We studied 33 cirrhotic patients with SBP. All of them were treated with ceftriaxone, 1.0 g IV, every 12 h...

  • Treatment in primary biliary cirrhosis. Parkhouse, J. // British Medical Journal (Clinical Research Edition);10/10/1987, Vol. 295 Issue 6603, p867 

    Focuses on the treatment of primary biliary cirrhosis in Great Britain. Assessment of thyroid functions with fatigue; Benefits of cholestyramine treatment; Certainty on the efficacy of the treatment affecting important pathogenic factors.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics